# Additional Benefit of Thoracic Impedance Monitoring (TIM) for Propofol-sedation Monitoring During PEG Placement

> **NCT04202029** · NA · COMPLETED · sponsor: **Georg Dultz** · enrollment: 173 (actual)

## Conditions studied

- Percutaneous Endoscopic Gastrostomy (PEG)

## Interventions

- **DEVICE:** thoracic impedance monitoring
- **DEVICE:** pulseoxymetry
- **DEVICE:** non-invasive blood preassure monitoring

## Key facts

- **NCT ID:** NCT04202029
- **Lead sponsor:** Georg Dultz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-04
- **Primary completion:** 2021-08-24
- **Final completion:** 2021-08-24
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2023-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04202029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04202029, "Additional Benefit of Thoracic Impedance Monitoring (TIM) for Propofol-sedation Monitoring During PEG Placement". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04202029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*